Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease

US Patent 10221146 · Granted Mar 5, 2019

Estimated economic value: $69,271,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

BRM/BRG1 inhibitors and uses thereof2025
Functionalized hydrogenated interpolymer with non-hydrogenated segment2025
Quinoline compounds and compositions for inhibiting EZH22025
IL4I1 inhibitors and methods of use2025
Semiconductor package structure2025
Substituted amino triazolopyrimidine and amino triazolopyrazine adenosine recept2025
Compounds and uses thereof2025
MLL1 inhibitors and anti-cancer agents2025
Substituted quinazoline compounds and methods of use thereof2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
1-pyrazolyl, 5-, 6-disubstituted indazole derivatives as LRRK2 inhibitors, pharm2025
Protoporphyrinogen oxidase inhibitors2025